NCT03755804 2026-02-23
Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
Clinical Trials
32 trialsNCT06144736 2025-09-15
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
Heinrich-Heine University, Duesseldorf
Phase 2 Recruiting
NCT06715592 2025-08-08
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2 Active not recruiting
NCT01873326 2025-07-03
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03712202 2024-11-06
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
City of Hope Medical Center
Phase 2 Active not recruiting
NCT04760327 2024-10-17
GynECT
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT01858922 2024-01-12
TXCH-HD-12A
Baylor College of Medicine
Phase 2 Completed
NCT00352027 2023-09-22
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT02292979 2022-08-19
BREACH
The Lymphoma Academic Research Organisation
Phase 2 Completed
NCT05395962 2022-05-27
Elechtra
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Recruiting
NCT02298283 2021-07-26
BRAPP2
The Lymphoma Academic Research Organisation
Phase 2 Completed
NCT01132807 2021-06-14
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00002715 2020-08-12
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
Stanford University
Phase 2 Completed
NCT02784054 2020-03-19
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
Samsung Medical Center
Phase 2 Unknown
NCT03527628 2019-11-18
(Optimist)
King Abdullah International Medical Research Center
Phase 2 Unknown
NCT03040180 2019-01-25
nECT
Zealand University Hospital
Phase 2 Unknown
NCT00369681 2018-08-27
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00136565 2018-08-23
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma
Lymphoma Study Association
Phase 2 Completed
NCT00026208 2018-07-24
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Stanford University
Phase 2 Completed
NCT00983944 2017-11-30
Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00079105 2017-03-30
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
Newcastle-upon-Tyne Hospitals NHS Trust
Phase 2 Completed
NCT02549742 2017-01-18
Electrochemotherapy on Head and Neck Cancer
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02782754 2016-05-25
Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma
Samsung Medical Center
Phase 2 Unknown
NCT00592111 2015-12-23
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00744653 2014-07-18
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.
Copenhagen University Hospital at Herlev
Phase 2 Terminated
NCT02161692 2014-06-12
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Completed
NCT00504504 2013-07-09
Rituximab and ABVD for Hodgkin's Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01404936 2013-02-01
Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00002524 2012-07-30
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00918593 2011-09-27
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
Copenhagen University Hospital at Herlev
Phase 2 Withdrawn
NCT00797472 2011-07-20
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
American Scitech International
Phase 2 Unknown
NCT00003110 2010-06-11
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase 2 Completed